Kotra Industries Bhd (XKLS:0002) Market Cap: RM550.2 Mil (As of Jun. 27, 2026)


XKLS:0002 Kotra Industries Bhd XKLS:0002
84 GF Score
Price RM3.71
GF Value RM4.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Kotra Industries Bhd Market Cap?

Kotra Industries Bhd XKLS:0002 84 Market Cap is RM550.2 Mil as of Jun. 27, 2026. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Kotra Industries Bhd ranks worse than 55.72% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kotra Industries Bhd's share price for the quarter that ended in Mar. 2026 was RM4.05. Kotra Industries Bhd's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 148.3 Mil. Therefore, Kotra Industries Bhd's market cap for the quarter that ended in Mar. 2026 was RM600.7 Mil.

Kotra Industries Bhd's quarterly market cap declined from Sep. 2025 (RM627.4 Mil) to Dec. 2025 (RM615.5 Mil) and declined from Dec. 2025 (RM615.5 Mil) to Mar. 2026 (RM600.7 Mil).

Kotra Industries Bhd's annual market cap declined from Jun. 2023 (RM759.4 Mil) to Jun. 2024 (RM630.3 Mil) and declined from Jun. 2024 (RM630.3 Mil) to Jun. 2025 (RM621.4 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kotra Industries Bhd's Enterprise Value for Today is RM530.4 Mil.


Kotra Industries Bhd  (XKLS:0002) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Kotra Industries Bhd Market Cap Related Terms


Kotra Industries Bhd Market Cap Historical Data

* Premium members only.

The historical data trend for Kotra Industries Bhd's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kotra Industries Bhd Market Cap Chart

Kotra Industries Bhd Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 350.63 591.90 759.37 630.33 621.44

Kotra Industries Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 621.44 621.44 627.37 615.50 600.67

XKLS:0002 vs ZTS, UTHR, VTRS: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kotra Industries Bhd Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Market Cap distribution charts can be found below:

* The bar in red indicates where Kotra Industries Bhd's Market Cap falls into.


XKLS:0002
84GF Score
Kotra Industries Bhd XKLS:0002
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kotra Industries Bhd Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Kotra Industries Bhd's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as

Market Cap (A: Jun. 2025 )=Share Price (A: Jun. 2025 )*Shares Outstanding (EOP) (A: Jun. 2025 )
=RM4.19*148.314
=RM621.4

Kotra Industries Bhd's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=RM4.05*148.314
=RM600.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of RM550.2 Mil mean?
Kotra Industries Bhd (XKLS:0002) has a Market Cap of RM550.2 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kotra Industries Bhd and its competitors. According to the industry distribution chart, Kotra Industries Bhd ranks #570 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 55.7%.
Is Kotra Industries Bhd's Market Cap too high?
Kotra Industries Bhd's current Market Cap is RM550.2 Mil. Based on the distribution chart, Kotra Industries Bhd ranks #570 out of 1023 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #570 out of 1023 companies for Market Cap. This places Kotra Industries Bhd in the lower half of its industry. The industry median Market Cap is 205.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current Market Cap is RM550.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.33, compared to a current price of RM3.71 — trading 14.3% below its estimated fair value. The current Market Cap is RM550.2 Mil. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Market Cap is RM550.2 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?

Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued. The current stock price of RM3.71 is trading 14.3% below its estimated GF Value™ of RM4.33. GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0002:

  • Market Cap: RM550.2 Mil
  • GF Value™: RM4.33 vs. price of RM3.71 (14.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kotra Industries Bhd Business Description

Address Jalan TTC 12, No. 1, 2 & 3, Cheng Industrial Estate, Melaka, MYS, 75250
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score

Get the complete analysis for XKLS:0002

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.71
Price
RM4.33
GF Value